Dorothee von Laer

Publications

• Oncolytic Activity of the Rhabdovirus VSV-GP Against Prostate Cancer
  International Journal of Cancer. Apr, 2018  |   Pubmed ID: 29696636
• The Oncolytic Virus VSV-GP Is Effective Against Malignant Melanoma
  Viruses. 03, 2018  |   Pubmed ID: 29498639
• No Molecular or Serological Evidence of Zikavirus Infection Among Healthy Blood Donors Living in or Travelling to Regions Where Aedes Albopictus Circulates
  PloS One. 2017  |   Pubmed ID: 28542611
• Factors Affecting HPV Vaccine Acceptance in West Austria: Do We Need to Revise the Current Immunization Scheme?
  Papillomavirus Research (Amsterdam, Netherlands). 12, 2016  |   Pubmed ID: 29074178
• Application of Interferon Modulators to Overcome Partial Resistance of Human Ovarian Cancers to VSV-GP Oncolytic Viral Therapy
  Molecular Therapy Oncolytics. 2016  |   Pubmed ID: 27738655
• Exclusive Transduction of Human CD4+ T Cells Upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
  Journal of Immunology (Baltimore, Md. : 1950). Sep, 2015  |   Pubmed ID: 26232436
• Low Prevalence of HPV Detection and Genotyping in Non-muscle Invasive Bladder Cancer Using Single-step PCR Followed by Reverse Line Blot
  World Journal of Urology. Dec, 2015  |   Pubmed ID: 25786709
• C Peptides As Entry Inhibitors for Gene Therapy
  Advances in Experimental Medicine and Biology. 2015  |   Pubmed ID: 25757622
• Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
  Cancer Research. Jul, 2014  |   Pubmed ID: 24812275